Pairnomix Information

Pairnomix launched at the start of 2016 with the goal of enabling the practice of precision medicine. We are committed to improving the lives of people with rare disease through our personalized genetic research services. Our process involves creating a model of a patient’s genetic mutation, learning about the functional consequences of that mutation, testing approved drugs against the model to discover new treatment options, and delivering our findings to the patient’s physician. We work with top genetic researchers, provide a very high level of support for our patients, and generate comprehensive reports that are reviewed by our world-class advisory board. Our goal is to help patients better understand their rare genetic mutation—and ultimately, to help physicians discover potential new treatment options.